Case: 20-1933 Document: 34 Page: 1 Filed: 07/13/2020
`
`20-1933
`
`Biogen International GmbH v. Mylan Pharmaceuticals Inc.
`
`Mylan Pharmaceuticals Inc.
`
`N.D. W. Va.
`
`1:17-cv-116
`
`patent infringement (ANDA)
`
`Mylan seeks affirmance of the district court's ruling that all claims-in-suit are
`invalid for lack of adequate written description.
`
`The district court entered a judgment of patent invalidity.
`
`The district court found that the claims that Biogen added to the application in
`2011 lacked written-description support in the specification filed in 2007.
`
`4
`
`6/22/20
`
`
`
`Case: 20-1933 Document: 34 Page: 2 Filed: 07/13/2020
`
`Mylan Pharm. Inc. v. Biogen MA Inc., No. 20-1673 (Fed. Cir.).
`
`Mylan expects Biogen to challenge the district court's ruling that the claims are
`invalid for lack of written description.
`
`4
`
`4
`
`Not amenable given the outcome before the district court and the settlement talks that
`have already occurred.
`
`Nathan K. Kelley
`
`7/13/20
`
`/s/Nathan K. Kelley
`
`4
`
`4
`
`
Still Working On It
This document is taking longer than usual to download. This can
happen if we need to contact the court directly to obtain the
document and their servers are running slowly.
Give it another minute or two to complete, and then try the
refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
One Moment Please
The filing “”
is large (MB) and is being
downloaded.
Please refresh this page in a few minutes to see if the
filing has been downloaded. The filing will also be emailed
to you when the download completes.
Sealed Document
We are unable to display this document, it may be under a court
ordered seal.
If you have proper credentials to access the file, you may proceed
directly to the court's system using your government issued username
and password.
Access Government Site